Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria
about
Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malariaThe structure of Mycobacteria 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase, an essential enzyme, provides a platform for drug discoveryInhibition of 1-Deoxy- d -Xylulose-5-Phosphate Reductoisomerase by Lipophilic Phosphonates: SAR, QSAR, and Crystallographic StudiesMolecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparumAlteration of the Flexible Loop in 1-Deoxy- d -xylulose-5-phosphate Reductoisomerase Boosts Enthalpy-Driven Inhibition by FosmidomycinTargeting an Aromatic Hotspot in Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase with β-Arylpropyl Analogues of FosmidomycinExperimental Genetics of Plasmodium berghei NFU in the Apicoplast Iron-Sulfur Cluster Biogenesis PathwayFosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathwaysFive questions about non-mevalonate isoprenoid biosynthesisBioorganometallic mechanism of action, and inhibition, of IspHDeciphering the late biosynthetic steps of antimalarial compound FR-900098.Antimalarial compounds in Phase II clinical development.Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malariaPharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malariaInadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.Thermodynamic Investigation of Inhibitor Binding to 1-Deoxy-D-Xylulose-5-Phosphate ReductoisomerasePlasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target.Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway.Discovery of the antibiotic phosacetamycin via a new mass spectrometry-based method for phosphonic acid detection.Update on clindamycin in the management of bacterial, fungal and protozoal infections.FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicityBiochemistry of the non-mevalonate isoprenoid pathway.Drug repositioning in the treatment of malaria and TB.Isoprenoid biosynthesis in the erythrocytic stages of Plasmodium falciparum.The isoprenoid-precursor dependence of Plasmodium spp.Emerging drugs for malaria.An in silico structural insights into Plasmodium LytB protein and its inhibition.Clinical pathologic conference case 5: agranulocytosis.Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.The apicoplast: now you see it, now you don't.Inhibition of the Fe(4)S(4)-cluster-containing protein IspH (LytB): electron paramagnetic resonance, metallacycles, and mechanisms.Pharmacodynamics of antimalarial chemotherapy.Improved efficacy of fosmidomycin against Plasmodium and Mycobacterium species by combination with the cell-penetrating peptide octaarginine.Biosynthesis of isoprenoids: studies on the mechanism of 2C-methyl-D-erythritol-4-phosphate synthase.Tropical medicine at the University of Tübingen.Drugs in Development for Malaria.
P2860
Q21034149-C47F0AFE-2B1E-4AB8-B57A-A6E286919936Q27648874-2440B0E8-DC75-4DB2-A5E2-42B3F8520A66Q27667791-7538E7F1-39E8-41D3-BC48-50C2AF0535ACQ27677409-5BF81C89-3247-4C00-B4CD-E096E1E11FD8Q27683779-D5D9C37B-E2DE-402A-AFEA-2A46372B630CQ27724266-6C614BB9-6950-4817-A1D3-AF5177C78732Q27972803-B07FB81D-0BC7-4EE5-A1F5-57F5DE6D3596Q27974683-F1DAB304-B2C2-48E8-B1D9-3AB3BB0E309CQ28478574-FB99D604-D66A-4E80-8EC4-78A4302C8086Q28748453-25EA95E0-D396-45BB-BBD4-881FB3940016Q33645098-EE5BF064-8546-438D-8E5A-09A9361AACCAQ34456807-D600917E-CAB2-4C1D-80C9-42313A9E5A6DQ35153938-83F0ACBA-D0C3-4F74-907A-0E3062ECCD77Q35678194-F7419C2B-77FE-437C-913D-66ED04D0B4B3Q35759028-0F43F42C-6F5D-4F11-AD52-F05BA0F4A996Q35850868-84D3255F-BF9D-44A4-AA52-C59DDBFD752DQ36018812-EBC0C66F-283C-4916-92C9-3D48ED066EA2Q36290683-1D15D1C0-6D7D-41F8-93B9-22DBBE0B1382Q36467783-5C17D160-11BD-4CA5-8BF4-DFBCD6D8D41FQ36817067-AD0122C7-4B1C-4FBF-BE6A-2C39BE058581Q36853334-C3F23999-09CB-4399-9F67-3B2F14B8DE32Q36967293-10AAA34A-7323-455A-866D-14A12B5E0D1DQ37189932-43394468-091F-4CEC-9F3E-6BFF9460F49CQ37899789-0688D3D4-8343-4B87-B985-6E43E5D5A1A2Q37924298-69D3E847-0399-40D2-B7BB-111AA70610EAQ37924610-3A88F19E-A38C-425B-928B-866D8D0DF3E8Q38007363-2CAE3508-B8B1-482F-8D2E-A807336890A1Q38027179-48A811CA-DA10-4BE4-946F-74DE04693412Q38396474-FD715E18-D0FD-4A82-A2E7-23D4C43DD738Q38432599-69B8D0F2-1468-452A-9A6F-1FAC5CCA60C8Q38558100-FD2794A2-595D-402A-9DB0-7B6590A4F7B6Q38856166-B2FCEE7F-2492-4B06-BC9E-9B901EF9B41DQ38988845-B4FB0E63-3CCF-4201-A0F6-232A11659E21Q40685503-187ACA23-1E95-4572-90EE-7D6EF5D07B7CQ41937695-5F451211-A2A5-4964-B703-C77BD4479740Q42710241-CBBDE6B0-9D7D-4DC0-A528-EC7740790739Q46491242-D886A361-57B5-47D8-94F9-70BBEE4E5661Q47938411-836BD656-4246-4A6C-A9FE-FA41DE57A7B5Q55278895-6CEFE56D-2B25-49EC-B858-6A1C73812E06
P2860
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@ast
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@en
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@nl
type
label
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@ast
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@en
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@nl
prefLabel
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@ast
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@en
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@nl
P2093
P2860
P50
P356
P1476
Fosmidomycin plus clindamycin ...... Plasmodium falciparum malaria
@en
P2093
Ayola A Adegnika
Bénido Impouma
David Hutchinson
Hassan Jomaa
Ingrid Lundgren
Jochen Wiesner
Jürgen F J Kun
Pierre-Blaise Matsiegui
Sunny Oyakhirome
P2860
P304
P356
10.1128/AAC.00392-06
P407
P577
2006-08-01T00:00:00Z